Reymundo Lozano, MD, MS, associate professor of Psychiatry, Genetics and Genomic Sciences, and Pediatrics and Department of Pediatrics, is a pediatric and adult clinical geneticist with neurodevelopmental and aging research training. He is the director of the Mt. Sinai Fragile X Spectrum Disorder Clinic, and as a collaborator on clinical trials in Fragile X syndrome, Dr. Lozano is committed to finding new pharmacological treatments.

Dr. Lozano enjoys working with the Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome scientific and medical communities, patients, and families utilizing current and innovative treatment strategies to ameliorate patients’ medical challenges. Dr. Lozano is a member of the NFXF board of directors and the Clinical Trials Committee.